Total Payments
$3,625
2024 Payments
$1,554
Companies
18
Transactions
92
Medicare Patients
4,335
Medicare Billing
$471,800
Payment Breakdown by Category
Food & Beverage$3,205 (88.4%)
Education$419.94 (11.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,205 | 86 | 88.4% |
| Education | $419.94 | 6 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $540.21 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $491.43 | 9 | $0 (2024) |
| ABBVIE INC. | $467.59 | 18 | $0 (2024) |
| Lilly USA, LLC | $414.15 | 9 | $0 (2024) |
| Amgen Inc. | $324.42 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $254.33 | 12 | $0 (2024) |
| GENZYME CORPORATION | $247.32 | 4 | $0 (2024) |
| Incyte Corporation | $170.90 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $162.35 | 4 | $0 (2024) |
| Galderma Laboratories, L.P. | $127.63 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,554 | 45 | ABBVIE INC. ($262.94) |
| 2023 | $1,442 | 34 | Sun Pharmaceutical Industries Inc. ($301.92) |
| 2022 | $301.42 | 5 | Lilly USA, LLC ($118.75) |
| 2021 | $151.67 | 3 | Janssen Biotech, Inc. ($85.00) |
| 2020 | $96.33 | 4 | Amgen Inc. ($78.01) |
| 2017 | $79.99 | 1 | Janssen Biotech, Inc. ($79.99) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.88 | General |
| 11/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $29.08 | General |
| 11/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.11 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.89 | General |
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.32 | General |
| 08/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.62 | General |
| 08/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.51 | General |
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: DERMATOLOGY | ||||||
| 06/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: DERMATOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.51 | General |
| Category: Dermatology | ||||||
| 06/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: DERMATOLOGY | ||||||
| 05/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $115.57 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Immunology | ||||||
| 05/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $108.41 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,104 | 2,880 | $541,331 | $109,398 |
| 2022 | 9 | 1,080 | 2,832 | $561,473 | $115,121 |
| 2021 | 9 | 1,059 | 2,711 | $584,799 | $124,271 |
| 2020 | 10 | 1,092 | 3,053 | $612,799 | $123,009 |
Total Patients
4,335
Total Services
11,476
Medicare Billing
$471,800
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 351 | 715 | $243,250 | $48,908 | 20.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 226 | 354 | $93,870 | $18,296 | 19.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 158 | 201 | $79,465 | $17,227 | 21.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 39 | 64 | $36,822 | $8,619 | 23.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 221 | 1,417 | $51,097 | $7,734 | 15.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $15,709 | $3,357 | 21.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 55 | 72 | $13,380 | $3,185 | 23.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 17 | 20 | $7,736 | $2,073 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 357 | 777 | $264,343 | $54,052 | 20.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 150 | 211 | $83,419 | $18,258 | 21.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 200 | 298 | $79,021 | $15,812 | 20.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 194 | 1,311 | $47,275 | $7,248 | 15.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 32 | 49 | $28,192 | $6,948 | 24.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 56 | 91 | $16,911 | $4,247 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 42 | 42 | $17,832 | $3,054 | 17.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 26 | 27 | $14,423 | $2,966 | 20.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 23 | 26 | $10,056 | $2,534 | 25.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 346 | 905 | $307,890 | $63,721 | 20.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 173 | 236 | $91,303 | $20,839 | 22.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 170 | 253 | $65,248 | $13,798 | 21.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 64 | 81 | $31,329 | $7,173 | 22.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 166 | 1,068 | $35,369 | $6,079 | 17.2% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 70 | 94 | $17,469 | $4,557 | 26.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $14,740 | $3,157 | 21.4% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 23 | 24 | $12,821 | $2,668 | 20.8% |
About Dr. Kathleen White, D.O
Dr. Kathleen White, D.O is a Internal Medicine healthcare provider based in Marlborough, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003907080.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathleen White, D.O has received a total of $3,625 in payments from pharmaceutical and medical device companies, with $1,554 received in 2024. These payments were reported across 92 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,205).
As a Medicare-enrolled provider, White has provided services to 4,335 Medicare beneficiaries, totaling 11,476 services with total Medicare billing of $471,800. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Marlborough, MA
- Active Since 09/27/2006
- Last Updated 12/19/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003907080
Products in Payments
- TREMFYA (Drug) $460.22
- ILUMYA (Biological) $334.44
- Otezla (Drug) $324.42
- RINVOQ (Biological) $309.46
- TALTZ (Drug) $271.74
- DUPIXENT (Biological) $228.96
- COSENTYX (Drug) $225.25
- OPZELURA (Drug) $170.90
- SKYRIZI (Biological) $158.13
- LITFULO (Drug) $121.86
- VTAMA (Drug) $80.84
- STELARA (Biological) $79.99
- Sotyktu (Drug) $52.22
- ADBRY (Biological) $27.45
- CYLTEZO (Biological) $26.80
- EBGLYSS (Drug) $23.66
- HYRIMOZ (Biological) $22.58
- AKLIEF (Drug) $15.72
- SEGLENTIS (Drug) $14.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marlborough
Marguerite Brackley, M.d, M.D
Internal Medicine — Payments: $291,890
Internal Medicine $291,890
Shunian He, Md, MD
Internal Medicine — Payments: $9,899
Internal Medicine $9,899
Sangeetha Punjabi, Md, MD
Internal Medicine — Payments: $2,062
Internal Medicine $2,062
Lalita Matta, M.d, M.D
Internal Medicine — Payments: $986.61
Internal Medicine $986.61
Dolly Geevarghese, Md, MD
Internal Medicine — Payments: $743.99
Internal Medicine $743.99
Jose Flores Cardillo, Md, MD
Internal Medicine — Payments: $530.66
Internal Medicine $530.66